CIAS
IBB icon

Capital Investment Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Capital Investment Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.51K Buy
+50
New +$8.59K ﹤0.01% 1158
2026
Q1 		– Sell
-22
Closed -$3.71K – 1233
2025
Q4 		$3.71K Hold
22
– – ﹤0.01% 1090
2025
Q3 		$3.18K Hold
22
– – ﹤0.01% 1035
2025
Q2 		$2.78K Hold
22
– – ﹤0.01% 1016
2025
Q1 		$2.81K Sell
22
-4,331
-99% -$587K ﹤0.01% 949
2024
Q4 		$576K Buy
4,353
+13
+0.3% +$1.83K 0.06% 262
2024
Q3 		$632K Buy
4,340
+20
+0.5% +$2.89K 0.06% 253
2024
Q2 		$593K Sell
4,320
-124
-3% -$16.6K 0.06% 261
2024
Q1 		$610K Buy
4,444
+4,312
+3,267% +$589K 0.07% 268
2023
Q4 		$17.9K Hold
132
– – ﹤0.01% 780
2023
Q3 		$16.1K Sell
132
-400
-75% -$50.9K ﹤0.01% 747
2023
Q2 		$67.5K Sell
532
-3,167
-86% -$411K 0.01% 576
2023
Q1 		$478K Buy
3,699
+1
+0% +$131 0.06% 266
2022
Q4 		$486K Buy
3,698
+70
+2% +$9.05K 0.06% 275
2022
Q3 		$424K Buy
3,628
+3,176
+703% +$394K 0.06% 278
2022
Q2 		$53K Buy
452
+430
+1,955% +$51K 0.01% 588
2022
Q1 		$3K Sell
22
-75
-77% -$9.77K ﹤0.01% 802
2021
Q4 		$15K Buy
97
+22
+29% +$3.41K ﹤0.01% 698
2021
Q3 		$12K Hold
75
– – ﹤0.01% 669
2021
Q2 		$12K Sell
75
-40
-35% -$6.16K ﹤0.01% 694
2021
Q1 		$17K Buy
115
+75
+188% +$11.9K ﹤0.01% 622
2020
Q4 		$6K Hold
40
– – ﹤0.01% 649
2020
Q3 		$5K Hold
40
– – ﹤0.01% 575
2020
Q2 		$5K Buy
+40
New +$5.1K ﹤0.01% 515
2019
Q3 		– Sell
-30
Closed -$3K – 1413
2019
Q2 		$3K Hold
30
– – ﹤0.01% 1225
2019
Q1 		$3K Hold
30
– – ﹤0.01% 1052
2018
Q4 		$3K Buy
+30
New +$3.18K ﹤0.01% 1002

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Capital Investment Advisory Services's IBB Position: Q2 2026 in Review

Capital Investment Advisory Services opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 50 shares worth $9.51K. The stake represents ﹤0.01% of the portfolio and ranks #1158 among its holdings. This is a return to the name: Capital Investment Advisory Services previously reported a position in IBB as recently as Q4 2025.

Capital Investment Advisory Services first reported a position in IBB in Q4 2018 and has held it in 27 quarters since. The position peaked at $632K in Q3 2024. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Capital Investment Advisory Services held 50 shares of iShares Biotechnology ETF worth $9.51K as of Q2 2026.
  • iShares Biotechnology ETF was a new Capital Investment Advisory Services position in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Capital Investment Advisory Services's portfolio in Q2 2026, its #1158 holding.
  • Capital Investment Advisory Services first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 27 quarters since.
  • Capital Investment Advisory Services's iShares Biotechnology ETF position peaked at $632K in Q3 2024.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.